Search
Transmedics Group Inc
TMDXAdd to Watchlist
78.790USD
+5.570+7.61%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.70BMarket Cap
15.61P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Transmedics Group Inc is 7.85, ranking 116 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 148.50, with a high of 170.00 and a low of 114.00.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
123.100
Target Price
+68.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Transmedics Group Inc
TMDX
13
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Transmedics Group Inc's expected revenue for the next quarter?
Transmedics Group Inc's expected revenue is 184.23M.
What is Transmedics Group Inc's price target?
Analysts forecast that Transmedics Group Inc's price target is USD 148.50, with the highest forecast at USD 170.00 and the lowest forecast at USD 114.00.
How have Transmedics Group IncTMDX's recent earnings per share performed?
The market expectation was USD 0.21, while Transmedics Group IncTMDX's earnings per share (EPS) for the previous quarter was USD 3.08. EPS for the next quarter is expected at USD 0.56.
What is the analyst rating for Transmedics Group Inc?
Based on the ratings of Transmedics Group Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
